Last Update 08 Feb 26
Fair value Increased 25%NVST: Improved Execution And Higher Future P/E Could Drive Stronger Earnings Power
Envista Holdings' analyst fair value estimate has shifted from $28.00 to $35.00, as analysts broadly raise price targets and upgrade ratings, citing improved growth execution and updated assumptions for revenue, margins, and future P/E expectations.
Analyst Commentary
Across recent research updates, bullish analysts have moved in the same direction, lifting price targets and, in several cases, upgrading their ratings on Envista Holdings. The adjustments cluster over a short time window, which points to a broad reassessment of the company’s execution and potential growth profile rather than a one off reaction.
These reports reference updated assumptions for revenue, margins, and future P/E expectations, which together feed into higher fair value estimates. While each firm uses its own models, the common thread is that analysts are now willing to underwrite higher valuation multiples or higher forward earnings power than before.
Several firms have made multiple target changes in quick succession, and some have also shifted their stance from neutral to more constructive. For you as an investor, that sends a clear signal that the Street is reassessing the risk reward balance, with more weight being placed on Envista’s ability to execute against its current plan.
Below are the key bullish themes emerging from this wave of commentary.
Bullish Takeaways
- Price targets have been raised by a range of increments, including moves of US$1, US$2, US$3, US$4, and US$6. Taken together, these changes support the higher analyst fair value estimate of US$35.00 and reflect more constructive views on Envista’s earnings power and P/E potential.
- Multiple bullish analysts have upgraded their ratings, citing improved growth execution. This supports the idea that Envista is doing a better job converting its revenue opportunities into profits than previously assumed.
- Repeated target lifts from the same firms over a short period suggest that positive factors such as updated margin assumptions and revenue expectations are not viewed as one off. Instead, they are treated as meaningful inputs to their valuation work.
- The clustering of upgrades and target increases, including moves tied explicitly to improved execution, contributes to a more positive sentiment backdrop. This can influence how the market prices Envista relative to its historical P/E range and sector peers.
What's in the News
- Envista Holdings issued earnings guidance for the full year 2026, with core sales growth expected in a range of 2% to 4% (company guidance).
Valuation Changes
- The Fair Value Estimate has risen from US$28.00 to US$35.00, representing a sizeable reset in what analysts see as the central value anchor for Envista Holdings.
- The Discount Rate has moved slightly lower from 8.57% to 8.37%, indicating a modest change in how analysts are treating Envista’s risk profile in their models.
- The Revenue Growth assumption has shifted from 4.64% to 4.11%, pointing to a slightly more cautious view on future top line expansion in the forecasts being used.
- The Profit Margin assumption has moved from 12.58% to 9.16%, reflecting a lower modeled level of profitability in the updated work.
- The Future P/E has increased from 13.55x to 22.34x, meaning analysts are now using a higher valuation multiple when translating their earnings assumptions into fair value estimates.
Key Takeaways
- Aggressive cost cuts, innovative digital solutions, and global manufacturing initiatives are rapidly expanding margins, outpacing industry peers and fueling strong, sustained revenue growth.
- Strategic acquisitions and rising demand for restorative dentistry uniquely position Envista to dominate key markets and accelerate recurring, high-margin software and service revenue.
- Heavy reliance on traditional markets and technologies exposes Envista to shrinking patient growth, digital disruption, pricing pressures, and margin erosion from regulatory and cost challenges.
Catalysts
About Envista Holdings- Develops, manufactures, markets, and sells dental products in the United States, China, and internationally.
- Analyst consensus anticipates steady margin improvement from cost efficiency and restructuring, but the trajectory is likely understated as Envista's aggressive G&A cost reductions, sustained Spark unit cost declines, and proven ability to offset rising tariffs are unlocking operating leverage far ahead of industry peers, accelerating EBITDA margin expansion and potential EPS outperformance.
- While consensus expects digital dentistry adoption to be an incremental growth driver, Envista's deepening R&D investment and rapid rollout of AI-integrated imaging, diagnostics, and workflow solutions-combined with strong traction in premium digital offerings through DSOs-could fuel an outsized shift toward high-margin, recurring software and service revenue, materially enhancing net margins and long-term earnings power.
- Double-digit core revenue gains in emerging regions were achieved despite ongoing macro and regulatory headwinds, with local manufacturing expansion in China set to structurally lower costs and substantially increase share in underpenetrated, rapidly urbanizing markets, supporting resilient top-line growth and expanded margins.
- The accelerating aging of populations globally and increasing oral health awareness are combining to drive a supercycle in restorative procedures and elective dental treatments, positioning Envista to capture a disproportionate share of wallet in both premium implants and orthodontics, leading to sustained above-market revenue growth for years to come.
- Recent step-up in capital deployment for acquisitions, paired with a pristine balance sheet and robust free cash flow, uniquely positions Envista to act as an industry consolidator, creating rapid revenue synergies and new cross-selling opportunities that can trigger a material re-rating in forward earnings and drive multiple expansion.
Envista Holdings Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- This narrative explores a more optimistic perspective on Envista Holdings compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
- The bullish analysts are assuming Envista Holdings's revenue will grow by 4.6% annually over the next 3 years.
- The bullish analysts assume that profit margins will increase from 2.1% today to 7.3% in 3 years time.
- The bullish analysts expect earnings to reach $212.7 million (and earnings per share of $1.2) by about September 2028, up from $53.8 million today. The analysts are largely in agreement about this estimate.
- In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 22.3x on those 2028 earnings, down from 64.3x today. This future PE is lower than the current PE for the US Medical Equipment industry at 29.7x.
- Analysts expect the number of shares outstanding to decline by 3.44% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.41%, as per the Simply Wall St company report.
Envista Holdings Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Envista faces significant pressure from aging and stagnant population growth in developed markets such as North America and Europe, which could ultimately restrict the expansion of their patient base and limit long-term revenue growth.
- Ongoing heavy dependence on traditional dental technologies, along with the risk of underinvestment in digital innovation, raises the potential for lost market share and diminishing revenue as dental providers rapidly transition to digital workflows and competitors advance technologically.
- Heightened global regulatory scrutiny and increased tariffs are contributing to a rising cost structure, with the company already reporting margin dilution from tariffs and facing future risks of regulatory delays or compliance costs, which could erode profit margins over time.
- The growing consolidation among dental service organizations and group practices increases Envista's exposure to pricing pressures, potentially squeezing profit margins and restricting their ability to grow earnings.
- Envista's strong reliance on mature markets leaves it exposed to persistent currency fluctuations and stagnating demand, which may hamper revenue growth and diminish operating leverage, ultimately impacting net income.
Valuation
How have all the factors above been brought together to estimate a fair value?- The assumed bullish price target for Envista Holdings is $25.0, which is the highest price target estimate amongst analysts. This valuation is based on what can be assumed as the expectations of Envista Holdings's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $25.0, and the most bearish reporting a price target of just $17.0.
- In order for you to agree with the bullish analysts, you'd need to believe that by 2028, revenues will be $2.9 billion, earnings will come to $212.7 million, and it would be trading on a PE ratio of 22.3x, assuming you use a discount rate of 8.4%.
- Given the current share price of $20.81, the bullish analyst price target of $25.0 is 16.8% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Envista Holdings?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystHighTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystHighTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystHighTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
